Company Profile: Conceptus makes the Essure permanent birth control system, an innovative and proprietary medical device for women.Current Share Price: $14.62 (April 11) Potential Upside from March 31: 58.9% based on a price target of $23 Barrington's Take: Conceptus, which was added to Barrington's Best Ideas List in January, has faced three major headwinds including competition from Adiana, a change in coverage in France and a weak job market. But Barrington analysts still view the company as an appealing long-term growth story with attractive valuation. "Growth has been weaker than expected due to a combination of a new competitor in the market, a decrease in patient office visits and the elective nature of permanent sterilization procedures," analysts wrote. "Management expects the competitive and economic headwinds to persist over the near term. However, we expect the company's revenue growth to reaccelerate in the back half of 2011 due to the additional reps added to the sales force in 2010 becoming more productive."
PRGX Global (PRGX) Company Profile: PRGX Global provides recovery audit services to businesses and government agencies having numerous payment transactions. Current Share Price: $6.28 (April 11) Potential Upside from March 31: 65% based on a price target of $10 Barrington's Take: PRGX Global was a new addition to Barrington's top picks in January. The research firm says PRGX "is no longer a turnaround story but an emerging growth story and we expect 2011 to be even better as management continues to focus on execution." "
>To contact the writer of this article, click here: Robert Holmes. >To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet. >To submit a news tip, send an email to: email@example.com.